South Korea FDA Mandates Warning Labels On OTC Drugs' External Packaging
This article was originally published in PharmAsia News
Executive Summary
SEOUL - In a move to counter growing public concern over the safety of drugs, the South Korean government, beginning Jan. 1, is mandating warning labels on external packaging for over-the-counter drugs